Hochmann S, Mittermeir M, Santic R, Koszik F, Griessner L, Sonderegger A, et al. Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer. Sci Rep. 2018;8:12954 pubmed publisher

Yadav P, McLeod V, Nowell C, Selby L, Johnston A, Kaminskas L, et al. Distribution of therapeutic proteins into thoracic lymph after intravenous administration is protein size-dependent and primarily occurs within the liver and mesentery. J Control Release. 2018;272:17-28 pubmed publisher

Ingelsson B, Söderberg D, Strid T, Söderberg A, Bergh A, Loitto V, et al. Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG and non-CpG oligodeoxynucleotides of class C. Proc Natl Acad Sci U S A. 2018;115:E478-E487 pubmed publisher

Bijak M, Dziedzic A, Synowiec E, Sliwinski T, Saluk Bijak J. Flavonolignans Inhibit IL1-?-Induced Cross-Talk between Blood Platelets and Leukocytes. Nutrients. 2017;9: pubmed publisher

Chan L, Feeney O, Leong N, McLeod V, Porter C, Williams C, et al. An Evaluation of Optimal PEGylation Strategies for Maximizing the Lymphatic Exposure and Antiviral Activity of Interferon after Subcutaneous Administration. Biomacromolecules. 2017;18:2866-2875 pubmed publisher

McLeod V, Chan L, Ryan G, Porter C, Kaminskas L. Optimal PEGylation can improve the exposure of interferon in the lungs following pulmonary administration. J Pharm Sci. 2015;104:1421-30 pubmed publisher

Meixlsperger S, Leung C, Rämer P, Pack M, Vanoaica L, Breton G, et al. CD141+ dendritic cells produce prominent amounts of IFN-? after dsRNA recognition and can be targeted via DEC-205 in humanized mice. Blood. 2013;121:5034-44 pubmed publisher

Hansmann L, Groeger S, von Wulffen W, Bein G, Hackstein H. Human monocytes represent a competitive source of interferon-alpha in peripheral blood. Clin Immunol. 2008;127:252-64 pubmed publisher